SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-007128
Filing Date
2017-04-25
Accepted
2017-04-25 16:17:25
Documents
4
Period of Report
2017-06-05
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 SGMO-DEF14A-2017 sgmo-def14a_20170427.htm DEF 14A 1342747
2 GRAPHIC g20170424184623515245.jpg GRAPHIC 62246
3 GRAPHIC g20170424184616389243.jpg GRAPHIC 3766
4 GRAPHIC g20170424184623474244.jpg GRAPHIC 118305
  Complete submission text file 0001564590-17-007128.txt   1598209
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 17781279
SIC: 2836 Biological Products, (No Diagnostic Substances)